Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up

Macular telangiectasia

MONDO:1010184

An eye disorder characterized by retinal capillary network incompetence, dilatations, and thinning which can be uniocular or binocular and causes gradual deterioration of central vision.

12 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Macular telangiectasia type 2 (2) Macular telangiectasia type 1 (1) Macular telangiectasia type 3 (0)

Broader categories

Disease (618) Eye disorder (97) Human disease (14) Disorder of orbital region (3) Disorder of visual system (1) Disease by body system or component (0)
Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 2
Sort by
  • Simple supplement may slow vision loss in rare eye disease

    Disease control Not yet recruiting

    This phase 3 trial tests whether taking serine, a natural amino acid, twice a day can slow vision loss in people with MacTel type 2, a rare eye disease. About 120 participants will receive either serine or a placebo for 24 months, with regular eye exams and imaging. The study aim…

    Phase: PHASE3 • Sponsor: The Lowy Medical Research Institute Limited • Aim: Disease control

    Last updated Jun 27, 2026 08:11 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space